--- title: "Replimune Group, Inc. Stock 12‑Month Price Target Raised to $8.17, Implies 30% Downside" type: "News" locale: "en" url: "https://longbridge.com/en/news/291195279.md" description: "Replimune Group, Inc.'s average 12-month price target was raised to $8.17 by six analysts, up from $7.67, with forecasts ranging from $1 to $17. Based on the June 26 closing price, this implies a 30% downside. The consensus rating remains 'Hold' among eight covering analysts, comprising two buys, four holds, and two sells." datetime: "2026-06-29T22:20:05.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/291195279.md) - [en](https://longbridge.com/en/news/291195279.md) - [zh-HK](https://longbridge.com/zh-HK/news/291195279.md) generator: "portal-rs" --- # Replimune Group, Inc. Stock 12‑Month Price Target Raised to $8.17, Implies 30% Downside - According to estimates from 6 analysts, Replimune Group, Inc. stock's average price target has risen from $7.67 to $8.17, with forecasts ranging from $1 to $17 per share - Based on the Jun. 26 closing price, the updated target implies approximately 30% potential downside - Consensus rating remains at “Hold” across 8 covering analysts, with 2 Buys, 4 Holds and 2 Sells Explore more price target data and ratings for Replimune Group, Inc. on the , and track all previous and future analyst recommendations for Replimune Group, Inc. in the dedicated News Flow. **Disclaimer** Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice. ### Related Stocks - [REPL.US](https://longbridge.com/en/quote/REPL.US.md) ## Related News & Research - [Replimune grants CCO Michelle DiNapoli options for 150,000 shares at $15.58, plus 100,000 RSUs](https://longbridge.com/en/news/296394220.md) - [Quantinno Capital Management LP Increases Stock Position in Replimune Group, Inc. $REPL](https://longbridge.com/en/news/296198190.md) - [Starfighters Space, Inc. GAAP EPS of -$0.24](https://longbridge.com/en/news/296400745.md) - [Replimune FY27 Q1 net loss narrows to $69.8 million; R&D expenses fall to $49.3 million](https://longbridge.com/en/news/295931365.md) - [Orca Energy Group Inc. declares $0.50 dividend](https://longbridge.com/en/news/296359493.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**